BioSpace News Archive

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority (“BARDA”), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HH

Bimini Health Tech announced today it has acquired Healeon Medical, Inc. Healeon represents an excellent addition to Bimini’s family of autologous products, continuing its mission of discoverin

CyMedica completes early enrollment and launches rollover study of a clinical trial to evaluate the effectiveness of e-vive for reducing pain and improving function by increasing quadriceps strength in knee osteoarthritis patients. [16-June-2020] SCOTTSDALE, Ariz. , June 16, 2020 /PRNewswire/ -- CyMedica Orthopedics®, the leading combined muscle strengthening therapy

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Stéphane Bancel, Chief Executive Officer, will participate virtually in the BMO 2020 Prescriptions for Success Healthcare Conference on June 23 rd at 3:00 p.m. ET. A live webcast will be available und

Erasca, a company whose mission is to erase cancer, today announced the expansion of its leadership team with the appointment of Bao Truong as vice president of regulatory affairs and David Luo as vice president of clinical research and operations. “We are delighted to continue attracti

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announces that it will host its 2020 Annual Shareholders Meeting virtually due to public health concerns related to the COVID-19.

Allows industry and academia access to cGMP-grade, NIH-registered AgeX ESI human pluripotent stem cells for development of cellular therapeutics AgeX ESI cell lines are among only a few pluripotent stem cell lines from which derived cell therapy candidates have been granted FDA IND clearance to begin human trials Pluristyx will manufacture, market, and distribute Ready-to-Use™ and Ready-to-Differentiate™ ESI stem cell lines vialed and frozen o

C4 Therapeutics, Inc. (C4T), a biotechnology company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation, today announced the closing of a $170 million financing, including $150 million in Series B equity co-led by existing investor Cobro Ventures and new investor Perc

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has partnered with Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics, in a non-exclusive agreement to expand global access to SpeeDx infectious disease and antibiotic resistance tests and technology. This press release featu

RenovaCare, Inc. announced the appointment of new Chief Financial Officer and Board Secretary, Mr. Robert W. Cook, who has more than 20 years of experience in senior financial leadership roles in healthcare, pharmaceuticals, and medical devices, and in the finance sector alone has completed more than $10 billion in transactions.